TLR9 ligands induce S100A8 in macrophages via a STAT3-dependent pathway which requires IL-10 and PGE2

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Hsu, Kenneth ^a   Chung, Yuen Ming ^a   Endoh, Yasumi ^a,b   Geczy, Carolyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CALGRANULIN A; INTERLEUKIN 10; JANUS KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; STAT3 PROTEIN; TOLL LIKE RECEPTOR 9; IL10 PROTEIN, HUMAN; IL10 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; S100A8 PROTEIN, MOUSE; STAT3 PROTEIN, HUMAN; STAT3 PROTEIN, MOUSE; TLR9 PROTEIN, HUMAN; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CPG ISLAND; ESCHERICHIA COLI; GENE INDUCTION; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; DNA RESPONSIVE ELEMENT; DRUG EFFECTS; HELA CELL LINE; IMMUNOLOGY;

ANIMALS; CALGRANULIN A; CPG ISLANDS; DINOPROSTONE; DNA, BACTERIAL; ESCHERICHIA COLI; HELA CELLS; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 9;

EID: 84905454628     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103629     Document Type: Article

References (68)

1. Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Medzhitov R, Horng T (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703.
3. Smale ST (2010) Selective transcription in response to an inflammatory stimulus. Cell 140: 833-844.
4. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760.
5. Haas T, Metzger J, Schmitz F, Heit A, Muller T, et al. (2008) The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28: 315-323. (Pubitemid 351335308)
6. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13: 816-825.
7. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, et al. (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168: 4531-4537. (Pubitemid 34441357)
8. Jozsef L, Khreiss T, El Kebir D, Filep JG (2006) Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils. J Immunol 176: 1195-1202. (Pubitemid 43099723)
9. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. (2001) Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194: 863-869. (Pubitemid 32983021)
10. Barton GM, Kagan JC, Medzhitov R (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7: 49-56. (Pubitemid 41823868)
11. Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S (2002) Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 14: 1225-1231. (Pubitemid 35175229)
12. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, et al. (2006) Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439: 204-207. (Pubitemid 43083141)
13. Murray PJ, Smale ST (2012) Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 13: 916-924.
14. Ravasi T, Hsu K, Goyette J, Schroder K, Yang Z, et al. (2004) Probing the S100 protein family through genomic and functional analysis. Genomics 84: 10-22. (Pubitemid 38760126)
15. Odink K, Cerletti N, Bruggen J, Clerc J, Tarcsay L, et al. (1987) Two calcium-binding proteins ininfiltrate macrophages of rheumatoid arthritus. Nature 330: 80-82. (Pubitemid 17152420)
16. Zwadlo G, Bruggen J, Gerhards G, Schlegel R, Sorg C (1988) Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin exp Immunol 72: 510-515.
17. Aochi S, Tsuji K, Sakaguchi M, Huh N, Tsuda T, et al. (2011) Markedly elevated serum levels of calcium-binding S100A8/A9 proteins in psoriatic arthritis are due to activated monocytes/macrophages. Journal of the American Academy of Dermatology 64: 879-887.
18. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, et al. (2009) Anti-Infective Protective Properties of S100 Calgranulins. Antiinflamm Antiallergy Agents Med Chem 8: 290-305.
19. Xu K, Geczy CL (2000) IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 164: 4916-4923. (Pubitemid 30238097)
20. Endoh Y, Chung YM, Clark IA, Geczy CL, Hsu K (2009) IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA. J Immunol 182: 2258-2268.
21. Cornish CJ, Devery JM, Poronnik P, Lackmann M, Cook DI, et al. (1996) S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J Cell Physiol 166: 427-437. (Pubitemid 26042420)
22. Hsu K, Passey RJ, Endoh Y, Rahimi F, Youssef P, et al. (2005) Regulation of S100A8 by glucocorticoids. J Immunol 174: 2318-2326. (Pubitemid 40223981)
23. Xu K, Yen T, Geczy CL (2001) IL-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 166: 6358-6366. (Pubitemid 32440769)
24. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, et al. (2011) S100A9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation 123: 1216-1226.
25. Harrison CA, Raftery MJ, Walsh J, Alewood P, Iismaa SE, et al. (1999) Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J Biol Chem 274: 8561-8569. (Pubitemid 29164647)
26. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, et al. (2005) S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280: 41521-41529. (Pubitemid 41832213)
27. Gomes LH, Raftery MJ, Xing Yan W, Goyette JD, Thomas PS, et al. (2012) S100A8 and S100A9 - Oxidant scavengers in inflammation. Free Radic Biol Med 58: 170-186.
28. Lim SY, Raftery M, Cai H, Hsu K, Yan WX, et al. (2008) S-nitrosylated S100A8: novel anti-inflammatory properties. J Immunol 181: 5627-5636.
29. Zhao J, Endoh I, Hsu K, Tedla N, Endoh Y, et al. (2011) S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. Antioxid Redox Signal 14: 1589-1600.
30. Vogl T, Ludwig S, Goebeler M, Strey A, Thorey IS, et al. (2004) MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. Blood 104: 4260-4268. (Pubitemid 39620181)
31. Goyette J, Yan WX, Yamen E, Chung YM, Lim SY, et al. (2009) Pleiotropic roles of S100A12 in coronary atherosclerotic plaque formation and rupture. J Immunol 183: 593-603.
32. Gao JJ, Xue Q, Papasian CJ, Morrison DC (2001) Bacterial DNA and lipopolysaccharide induce synergistic production of TNF-alpha through a post-transcriptional mechanism. J Immunol 166: 6855-6860. (Pubitemid 32467231)
33. Niu G, Wright KL, Huang M, Song L, Haura E, et al. (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008. (Pubitemid 34270888)
34. Hu SP, Harrison C, Xu K, Cornish CJ, Geczy CL (1996) Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 87: 3919-3928. (Pubitemid 26130614)
35. Yi AK, Yoon JG, Yeo SJ, Hong SC, English BK, et al. (2002) Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J Immunol 168: 4711-4720. (Pubitemid 34441379)
36. Ishii KJ, Takeshita F, Gursel I, Gursel M, Conover J, et al. (2002) Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA-induced immune activation. J Exp Med 196: 269-274. (Pubitemid 34787517)
37. Murray PJ (2006) Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6: 379-386.
38. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, et al. (2008) Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 205: 2235-2249.
39. Seidel HM, Milocco LH, Lamb P, Darnell JE, Jr., Stein RB, et al. (1995) Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A 92: 3041-3045.
40. Shackleford TJ, Zhang Q, Tian L, Vu TT, Korapati AL, et al. (2011) Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells. Breast Cancer Res 13: R65.
41. Nacken W, Roth J, Sorg C, Kerkhoff C (2003) S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60: 569-580.
42. Nathan C (2002) Points of control in inflammation. Nature 420: 846-852.
43. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964. (Pubitemid 41746764)
44. Chen Y, Zhang J, Moore SA, Ballas ZK, Portanova JP, et al. (2001) CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int Immunol 13: 1013-1020. (Pubitemid 32750504)
45. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S (1994) Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179: 1695-1699. (Pubitemid 24129589)
46. Carl VS, Gautam JK, Comeau LD, Smith MF, Jr. (2004) Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. J Leukoc Biol 76: 735-742. (Pubitemid 39129108)
47. Kalinski P (2012) Regulation of immune responses by prostaglandin E2. J Immunol 188: 21-28.
48. Rodriguez M, Domingo E, Municio C, Alvarez Y, Hugo E, et al. (2014) Polarization of the Innate Immune Response by Prostaglandin E2: A Puzzle of Receptors and Signals. Mol Pharmacol 85: 187-197.
49. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150. (Pubitemid 34178297)
50. Yeo SJ, Gravis D, Yoon JG, Yi AK (2003) Myeloid differentiation factor 88-dependent transcriptional regulation of cyclooxygenase-2 expression by CpG DNA: role of NF-kappaB and p38. J Biol Chem 278: 22563-22573. (Pubitemid 36830312)
51. Akaogi J, Yamada H, Kuroda Y, Nacionales DC, Reeves WH, et al. (2004) Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. J Leukoc Biol 76: 227-236. (Pubitemid 38857191)
52. Goldsmith M, Avni D, Ernst O, Glucksam Y, Levy-Rimler G, et al. (2009) Synergistic IL-10 induction by LPS and the ceramide-1-phosphate analog PCERA-1 is mediated by the cAMP and p38 MAP kinase pathways. Mol Immunol 46: 1979-1987.
53. Liu YW, Chen CC, Tseng HP, Chang WC (2006) Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages. Cell Signal 18: 1492-1500.
54. Yeo SJ, Yoon JG, Hong SC, Yi AK (2003) CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression. J Immunol 170: 1052-1061.
55. Csoka B, Nemeth ZH, Virag L, Gergely P, Leibovich SJ, et al. (2007) A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to Escherichia coli. Blood 110: 2685-2695. (Pubitemid 47523193)
56. DiSepio D, Malhotra M, Chandraratna RA, Nagpal S (1997) Retinoic acid receptor-nuclear factor-interleukin 6 antagonism. A novel mechanism of retinoid-dependent inhibition of a keratinocyte hyperproliferative differentiation marker. J Biol Chem 272: 25555-25559. (Pubitemid 27438865)
57. Robb BW, Hershko DD, Paxton JH, Luo GJ, Hasselgren PO (2002) Interleukin-10 activates the transcription factor C/EBP and the interleukin-6 gene promoter in human intestinal epithelial cells. Surgery 132: 226-231. (Pubitemid 35024766)
58. Tanaka N, Hoshino Y, Gold J, Hoshino S, Martiniuk F, et al. (2005) Interleukin-10 induces inhibitory C/EBPbeta through STAT-3 and represses HIV-1 transcription in macrophages. Am J Respir Cell Mol Biol 33: 406-411. (Pubitemid 41416292)
59. Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunological Reviews 226: 205-218.
60. Jung M, Weigert A, Tausendschon M, Mora J, Oren B, et al. (2012) Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Mol Cell Biol 32: 3938-3948.
61. Saraiva M, O'Garra A (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
62. Fleming BD, Mosser DM (2011) Regulatory macrophages: setting the threshold for therapy. Eur J Immunol 41: 2498-2502.
63. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049. (Pubitemid 47517513)
64. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, et al. (2008) RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29: 2035-2043.
65. Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160: 1427-1435. (Pubitemid 28093444)
66. Sun Y, Lu Y, Engeland CG, Gordon SC, Sroussi HY (2013) The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice. Mol Immunol 53: 443-449.
67. Lim SY, Raftery MJ, Geczy CL (2011) Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. Antioxid Redox Signal 15: 2235-2248.
68. Hiroshima Y, Hsu K, Tedla N, Chung YM, Chow S, et al. (2014) S100A8 induces IL-10 and protects against acute lung injury. J Immunol 192: 2800-2811.